1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
03/15/2024 | ALB | Buy Now | Albemarle | $124.33 | 30.3% | Loop Capital | Christopher Kapsch | $168 → $162 | Maintains | Buy | Get Alert |
03/11/2024 | ALB | Buy Now | Albemarle | $124.33 | -34.85% | Morgan Stanley | Vincent Andrews | $90 → $81 | Maintains | Underweight | Get Alert |
03/08/2024 | ALB | Buy Now | Albemarle | $124.33 | 16.63% | Vertical Research | Kevin McCarthy | → $145 | Downgrade | Buy → Hold | Get Alert |
03/07/2024 | ALB | Buy Now | Albemarle | $124.33 | -9.92% | Mizuho | John Roberts | $115 → $112 | Maintains | Neutral | Get Alert |
03/07/2024 | ALB | Buy Now | Albemarle | $124.33 | 27.89% | Keybanc | Aleksey Yefremov | $178 → $159 | Maintains | Overweight | Get Alert |
03/01/2024 | ALB | Buy Now | Albemarle | $124.33 | — | Wolfe Research | Chris Parkinson | — | Initiates | → Peer Perform | Get Alert |
02/27/2024 | ALB | Buy Now | Albemarle | $124.33 | -7.5% | Mizuho | John Roberts | $105 → $115 | Maintains | Neutral | Get Alert |
02/16/2024 | ALB | Buy Now | Albemarle | $124.33 | 8.58% | Wells Fargo | Michael Sison | $140 → $135 | Maintains | Overweight | Get Alert |
02/16/2024 | ALB | Buy Now | Albemarle | $124.33 | 11% | RBC Capital | Arun Viswanathan | $140 → $138 | Maintains | Outperform | Get Alert |
02/16/2024 | ALB | Buy Now | Albemarle | $124.33 | 51.21% | Oppenheimer | Colin Rusch | $191 → $188 | Maintains | Outperform | Get Alert |
02/16/2024 | ALB | Buy Now | Albemarle | $124.33 | 43.17% | Keybanc | Aleksey Yefremov | $199 → $178 | Maintains | Overweight | Get Alert |
02/15/2024 | ALB | Buy Now | Albemarle | $124.33 | 0.54% | UBS | Joshua Spector | $137 → $125 | Maintains | Neutral | Get Alert |
02/09/2024 | ALB | Buy Now | Albemarle | $124.33 | -3.48% | Citigroup | Patrick Cunningham | $175 → $120 | Downgrade | Buy → Neutral | Get Alert |
01/30/2024 | ALB | Buy Now | Albemarle | $124.33 | 10.19% | UBS | Joshua Spector | $142 → $137 | Maintains | Neutral | Get Alert |
01/29/2024 | ALB | Buy Now | Albemarle | $124.33 | 4.56% | TD Cowen | David Deckelbaum | → $130 | Downgrade | Outperform → Market Perform | Get Alert |
01/23/2024 | ALB | Buy Now | Albemarle | $124.33 | 4.56% | Mizuho | Christopher Parkinson | $152 → $130 | Maintains | Neutral | Get Alert |
01/17/2024 | ALB | Buy Now | Albemarle | $124.33 | 53.63% | Oppenheimer | Colin Rusch | $308 → $191 | Maintains | Outperform | Get Alert |
01/11/2024 | ALB | Buy Now | Albemarle | $124.33 | 14.21% | UBS | Joshua Spector | $130 → $142 | Maintains | Neutral | Get Alert |
01/11/2024 | ALB | Buy Now | Albemarle | $124.33 | 8.58% | Deutsche Bank | Corinne Blanchard | $155 → $135 | Downgrade | Buy → Hold | Get Alert |
The latest price target for Albemarle (NYSE: ALB) was reported by Loop Capital on March 15, 2024. The analyst firm set a price target for $162.00 expecting ALB to rise to within 12 months (a possible 30.30% upside). 62 analyst firms have reported ratings in the last year.
The latest analyst rating for Albemarle (NYSE: ALB) was provided by Loop Capital, and Albemarle maintained their buy rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Albemarle, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Albemarle was filed on March 15, 2024 so you should expect the next rating to be made available sometime around March 15, 2025.
While ratings are subjective and will change, the latest Albemarle (ALB) rating was a maintained with a price target of $168.00 to $162.00. The current price Albemarle (ALB) is trading at is $124.33, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.